Immunosuppression and xenotransplantation of cells for cardiac repair

Annals of Thoracic Surgery

Volumn 77, Issue 2, 2004, Pages 737-744

  Xiao, Yong Fu ^a   Min, Jiang Yong ^a   Morgan, James P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN DERIVATIVE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CARDIOMYOPLASTY; CELL DEATH; CELL TRANSPLANTATION; CYTOLOGY; EMBRYO CELL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; FETUS CELL; GRAFT REJECTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN EMBRYO; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; MAMMAL CELL; METHODOLOGY; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SATELLITE CELL; SOMATIC CELL; STEM CELL; STEM CELL TRANSPLANTATION; SURGICAL RISK; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

EID: 0442323686     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.08.036     Document Type: Review

References (82)

1. Soonpaa M.H., Koh G.Y., Klug M.G., Field L.J. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science. 264:1994;98-101.
2. Chiu R.C.J., Zibaitis A., Kao R.L. Cellular cardiomyoplasty myocardial regeneration with satellite cell implantation . Ann Thorac Surg. 60:1995;12-18.
3. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature. 410:2001;701-706.
4. Min J.Y., Yang Y., Converso K.L., et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Applied Physiol. 92:2002;288-296.
5. Strauer B.E., Brehm M., Zeus T., et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr. 126:2001;932-938.
6. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106:2002;1913-1918.
7. Menasche P., Hagege A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet. 357:2001;279-280.
8. Perin E.C., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 107:2003;2294-2302.
9. Li R.K., Jia Z.Q., Weisel R.D., et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg. 62:1996;654-661.
10. Leor J., Patterson M., Quinones M.J., Kedes L.K., Kloner R.A. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat a potential method for repair of infarcted myocardium . Circulation. 94:(Suppl II):1996;II332-336.
11. Koh G.Y., Soonpaa M.H., Klug M.G., Field L.J. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol. 264:(Pt 2):1993;H1727-1733.
12. Tomita S., Li R.K., Weisel R.D., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 100:(Suppl II):1999;II247-II256.
13. Chedrawy E.G., Wang J.S., Nguyen D.M., Shum-Tim D., Chiu R.C. Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers anatomic basis for functional improvements . J Thorac Cardiovasc Surg. 124:2002;584-590.
14. Scorsin M., Hagege A.A., Marotte F., et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation. 96:(Suppl II):1997;II-188-193.
15. Scorsin M., Hagege A., Vilquin J.T., et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 119:2000;1169-1175.
16. Leor J., Prentice H., Sartorelli V., et al. Gene transfer and cell transplant an experimental approach to repair a ′broken heart' . Cardiovasc Res. 35:1997;431-441.
17. Li R.K., Weisel R.D., Mickle D.A., et al. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg. 119:2000;62-68.
18. Min J.Y., Sullivan M.F., Yang Y., et al. Significant improvement of heart function by co-transplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg. 74:2002;1568-1575.
19. Min J.Y., Yang Y., Sullivan M.F., et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg. 125:2003;361-369.
20. Yang Y., Min J.Y., Rana J.S., et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol. 93:2002;1140-1151.
21. Wang J.F., Yang Y., Wang G., et al. Embryonic stem cells attenuate viral myocarditis in murine model. Cell Transplant. 11:2002;753-758.
22. Liu Y., Song J., Liu W., et al. Growth and differentiation of rat bone marrow stromal cells does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovasc Res. 58:2003;460-468.
23. Reinecke H., Poppa V., Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol. 34:2002;241-249.
24. Wagers A.J., Sherwood R.I., Christensen J.L., Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2002;2256-2259.
25. Taylor D.A. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. Curr Control Trials Cardiovasc Med. 2:2001;208-210.
26. Hughes S. Cardiac stem cells. J Pathol. 197:2002;468-478.
27. Muller-Ehmsen J., Kedes L.H., Schwinger R.H., Kloner R.A. Cellular cardiomyoplasty - a novel approach to treat heart disease. Congest Heart Fail. 8:2002;220-227.
28. Orlic D., Hill J.M., Arai A.E. Stem cells for myocardial regeneration. Circ Res. 91:2002;1092-1102.
29. Anversa P., Leri A., Kajstura J., Nadal-Ginard B. Myocyte growth and cardiac repair. J Mol Cell Cardiol. 34:2002;91-105.
30. Strauer B.E., Kornowski R. Stem cell therapy in perspective. Circulation. 107:2003;929-934.
31. Delcarpio J.B., Claycomb W.C. Cardiomyocyte transfer into the mammalian heart. Cell-to-cell interactions in vivo and in vitro. Ann N Y Acad Sci. 752:1995;267-285.
32. Delcarpio J.B., Barbee R.W., Perry B.D., Claycomb W.C. Cardiomyocyte transfer into the rodent heart host cell interactions and angiogenesis . Circulation. 88:1993;I-139a.
33. Van Meter C.H., Claycomb W.C. Jr, Delcarpio J.B., et al. Myoblast transplantation in the porcine model A potential technique for myocardial repair . J Thorac Cardiovasc Surg. 110:1995;1142-1148.
34. Leor J., Patterson M., Quinones M.J., Kedes L.H., Kloner R.A. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation. 94:(Suppl II):1996;II332-336.
35. Watanabe E., Smith D.M. Jr, Delcarpio J.B., et al. Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplan. 7:1998;239-246.
36. Li T.S., Hamano K., Kajiwara K., et al. Prolonged survival of xenograft fetal cardiomyocytes by adenovirus-mediated CTLA4-Ig expression. Transplantation. 72:2001;1983-1985.
37. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 103:1999;697-705.
38. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 105:2002;93-98.
39. Saito T., Kuang J.Q., Bittira B., Al-Khaldi A., Chiu R.C. Xenotransplant cardiac chimera immune tolerance of adult stem cells . Ann Thorac Surg. 74:2002;19-24.
40. Reinecke H., Murry C.E. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol. 9:2000;337-344.
41. Haider K.H., Jiang S.J., Ye L., et al. Transient immunosuppression is effective for xenotransplantation of human myoblasts for cardiac repair in a porcine heart model. Circulation. 106:2002;II-15a.
42. Westfall M.V., Pasyk K.A., Yule D.I., Samuelson L.C., Metzger J.M. Ultrastructure and cell-cell coupling of cardiac myocytes differentiating in embryonic stem cell cultures. Cell Motil Cytoskeleton. 36:1997;43-54.
43. Kilborn M.J., Fedida D. A study of the developmental changes in outward currents of rat ventricular myocytes. J Physiol (Lond). 430:1990;37-60.
44. Rohwedel J., Maltsev V., Bober E., et al. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo developmentally regulated expression of myogenic determination genes and functional expression of ionic currents . Dev Biol. 164:1994;87-101.
45. Maltsev V.A., Rohwedel J., Hescheler J., Wobus A.M. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev. 44:1993;41-50.
46. Klug M.G., Soonpaa M.H., Field L.J. DNA synthesis and multinucleation in embryonic stem cell-derived cardiomyocytes. Am J Physiol. 269:1995;H1913-1921.
47. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest. 98:1996;216-224.
48. Westfall M.V., Samuelson L.C., Metzger J.M. Troponin I isoform expression is developmentally regulated in differentiating embryonic stem cell-derived cardiac myocytes. Dev Dyn. 206:1996;24-38.
49. Kehat I., Kenyagin-Karsenti D., Snir M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 108:2001;407-414.
50. Xu C., Police S., Rao N., Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res. 91:2002;501-508.
51. Naito H., Taniguchi S., Kawata T. Embryonic stem cell-derived cardiomyocyte transplantation into the infarcted myocardium. Heart Surg Forum. 6:2002;1.
52. Behfar A., Zingman L.V., Hodgson D.M., et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 16:2002;1558-1566.
53. Fandrich F., Dresske B., Bader M., Schulze M. Embryonic stem cells share immune-privileged features relevant for tolerance induction. J Mol Med. 80:2002;343-350.
54. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 6:2000;1282-1286.
55. Matzinger P. An innate sense of danger. Ann NY Acad Sci. 961:2002;341-342.
56. Matzinger P. The danger model a renewed sense of self . Science. 296:(5566):2002;301-305.
57. Anderson C.C., Matzinger P. Danger the view from the bottom of the cliff . Semin Immunol. 12:(3):2000;231-238.
58. Li R.K., Mickle D.A., Weisel R.D., et al. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation. 96:(Suppl):1997;II-179-186.
59. Fandrich F., Lin X., Chai G.X., et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med. 8:2002;171-178.
60. Morris P.J. The immunobiology of cell transplantation. Cell Transplant. 2:1993;7-12.
61. O'Shea K.S. Embryonic stem cell models of development. Anat Rec. 257:1999;32-41.
62. Beschorner W.E., Sudan D.L., Radio S.J., et al. Heart xenograft survival with chimeric pig donors and modest immune suppression. Ann Surg. 237:2003;265-272.
63. Billingham R.E., Brent L., Medawar P.B. Actively acquired tolerance of foreign cells. Nature. 172:1953;603-606.
64. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 30:2002;42-48.
65. Strom T.B., Field L.J., Ruediger M. Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine. Transplant Proc. 33:2001;3044-3049.
66. Ildstad S.T., Wren S.M., Boggs S.S., et al. Cross-species bone marrow transplantation. Evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat - mouse). J Exp Med. 174:1991;467-478.
67. Wu G., Korsgren O., van Rooijen N., Tibell A. Suppression of T cells results in long-term survival of mouse heart xenografts in C6-deficient rats. Xenotransplantation. 8:2001;303-309.
68. Perez-Terzic C., Behfar A., Mery A., et al. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res. 92:2003;444-452.
69. Poulsom R., Alison M.R., Forbes S.J., Wright N.A. Adult stem cell plasticity. J Pathol. 197:2002;441-456.
70. Terada N., Hamazaki T., Oka M., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 416:2002;542-545.
71. Ying Q.L., Nichols J., Evans E.P., Smith A.G. Changing potency by spontaneous fusion. Nature. 416:2002;545-548.
72. Markmann J.F., Campos L., Bhandoola A., et al. Genetically engineered grafts to study xenoimmunity a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts . Surgery. 116:1994;242-248.
73. Gochi E., Wu G.D., Wakiyama S., et al. Genetic control of the humoral responses to xenografts. III. Identification of the immunoglobulin V(H) genes responsible for encoding rat immunoglobin G xenoantibodies to hamster heart grafts. Transplantation. 68:1999;15-24.
74. Rideout W.M., Hochedlinger K., Kyba M., Daley G.Q., Jaenisch R. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell. 109:2002;17-27.
75. Chiu R.C. Adult stem cell therapy for heart failure. Expert Opin Biol Ther. 3:2003;215-225.
76. Al-Radi O.O., Rao V., Li R.K., Yau T., Weisel R.D. Cardiac cell transplantation closer to bedside . Ann Thorac Surg. 75:2003;S674-677.
77. Tucker A., Belcher C., Moloo B., et al. The production of transgenic pigs for potential use in clinical xenotransplantation microbiological evaluation . Xenotransplantation. 9:2002;191-202.
78. Specke V., Tacke S.J., Boller K., Schwendemann J., Denner J. Porcine endogenous retroviruses in vitro host range and attempts to establish small animal models . J Gen Virol. 82:(Pt 4):2001;837-844.
79. Specke V., Schuurman H.J., Plesker R., et al. Virus safety in xenotransplantation first exploratory in vivo studies in small laboratory animals and non-human primates . Transpl Immunol. 9:2002;281-288.
80. Gollackner B., Mueller N.J., Houser S., et al. Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation. Transplantation. 75:2003;1841-1847.
81. Persson M.O., Persson N.H., Ranstam J., Hermeren G. Xenotransplantation public perceptions rather cells than organs . Xenotransplantation. 10:2003;72-79.
82. Imai M., Takigami K., Guckelberger O., et al. Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation. 70:2000;864-870.